Dr. Frank Agbogbo is Vice President of Process Development at Forge Biologics. He has nearly 20 years of experience in the industry. Previously, Dr. Agbogbo was Senior Director of Process Development at Cytovance Biologics where he oversaw cell line development, cell culture, strain development and fermentation.

He was at Cytovance for over seven years where he took increasing responsibilities from Director of Fermentation to Director of Process Development with the supervision of the Upstream and Downstream teams. Prior to Cytovance, Dr. Agbogbo was the Application Technology Manager at Mascoma Corporation where he contributed to the launch of two commercial products. He was also a Principal Scientist at ICM, Inc. and a Scientist at Novozymes.

Dr. Agbogbo’s experience includes process development, Design of Experiments (DoE), process optimization, process characterization and scale-up from R&D to manufacturing (cGMP and non-cGMP). He was co-chair at scientific conferences such as the Society for Industrial Microbiology and Biotechnology Annual Meeting (SIMB) and Recent Advances in Fermentation Technology (RAFT) on many topics, including process optimization, scale-up, DoE, process characterization, downstream development and process analytical technologies.

He has co-authored over 15 peer-reviewed publications and contributed to five patents. Dr. Agbogbo earned a BS in Chemical Engineering from Kwame Nkrumah University of Science and Technology, a PhD in Chemical Engineering from Texas A&M University, and an MBA with a certificate in Entrepreneurship from the Price College of Business, Oklahoma University.